Abstract: A series of novel ligustrazine-triterpenes derivatives was designed, synthesized and screened for their cytotoxicity against five cancer cell lines HepG2, Hela, and Madin-Darby canine kidney (MDCK). Current study suggested that most of the ligustrazine-triterpenes conjunctions showed better cytotoxicity than the starting materials. In particular, compound 4a exhibited better cytotoxic activity (IC50 < 5.23 μM) against Bel-7402, HT-29, MCF-7, Hela, and HepG2 than the standard anticancer drug cisplatin (DDP). The cytotoxicity selectivity detection revealed that 4a exhibited low cytotoxicity (IC50 > 20 μM) towards MDCK cells. A combination of fluorescence staining observation and flow cytometric analysis indicated that 4a could induce HepG2 cell apoptosis. Further studies suggested that 4a-induced apoptosis is mediated through depolarization of the mitochondrial membrane potential and increase of concentration. In addition, the structure-activity relationships of these derivatives were briefly discussed.
Introduction
Natural products play a highly significant role in the development process of drug discovery [1] . This was particularly evident in the areas of anti-cancer drugs; over 60% of FDA approved anti-tumor drugs were shown to be of natural origin, such as the best known anticancer drugs vinblastine, etoposide and paclitaxel [2] . In recent years, several pentacyclic triterpenoids, such as oleanolic acid (OA), ursolic acid (UA), glycyrrhetic acid (GA) and betulinic acid (BA), were found to possess remarkable anti-proliferative and apoptosis-inducing activity in various cancer cell lines [3] [4] [5] [6] . Moreover, pentacyclic triterpenoids and their derivatives possessed strong selective cytotoxicity on human carcinoma cells, but not on normal cells [7] [8] [9] [10] . This has stimulated interest in using pentacyclic triterpenoids as the scaffold to synthesize new anticancer agents [11] [12] [13] [14] [15] [16] .
Structural modification of bioactive natural products according to combination principle is an important approach in the search for new lead compounds [17] [18] [19] [20] . In our previous work of this field, we had designed and synthesized a series of ligustrazine-triterpenes derivatives, among which some compounds showed promising selective cytotoxicity on human carcinoma cells. It revealed that the introduction of ligustrazine could increase the cytotoxicity and selectivity of these compounds [17, 20] . Moreover, the oral bioavailability of ligustrazine-triterpenes ester derivative was checked using a rat model. Ligustrazine-triterpenes ester derivative was metabolic stability following oral administration [21, 22] .
In our continuous effort to develop new antitumor agents, we designed and synthesized a series of novel ligustrazine derivatives by combination ligustrazine with several pentacyclic triterpenoids. All newly synthesized compounds were fully characterized. With their cytotoxicity was evaluated on a panel of human tumor cell lines, including Bel-7402, HepG2, HT-29, Hela, MCF-7. The antineoplastic drug cisplatin (DDP) was selected as the positive control, with the Madin-Darby canine kidney cell line (MDCK) was used to test the nephrotoxicity of the ligustrazine-triterpenes derivatives and DDP. The antitumor mechanism was also investigated by fluorescence staining observation and flow cytometric analysis on treated HepG2 cells. In addition, the structure-activity relationships (SARs) of these novel compounds were also discussed.
Results and Discussion

Chemistry
All the designed derivatives were synthesized via the routes outlined in Schemes 1 and 2. As the important intermediates, 2-(bromomethyl)-3,5,6-trimethylpyrazine (1) and 3,5,6-trimethylpyrazine-2-carboxylic acid (2) were prepared according to our previous study [17] . As shown in Scheme 1, the pentacyclic triterpenes underwent alkylation reaction with the intermediate 1 to afford compounds 1a-4a. Subsequently, Compounds 1a-4a were further reacted with 2 in the presence of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) and 4-dimethylaminopyridine (DMAP) to generate the target compounds 1b-4b. The synthesis of compounds 1c-4c and 1d-4d were conducted according to the procedures in Scheme 2. First, the pentacyclic triterpenes were reacted with benzyl bromide under alkaline conditions to form the intermediates 4, 5, 6 and 7. Subsequently, the intermediates were further treated with 2 to generate the target compounds 1c-4c, respectively. Finally, the benzyl groups of compounds 1c-4c were taken off by catalytic hydrogenolysis over Pd(OH)2/C to give the target compounds 1d-4d. The structures of all target compounds were confirmed using 1 H-NMR, 13 C-NMR and high-resolution mass spectrometer (HRMS). 
Cytotoxicity Assay
The cytotoxicity of ligustrazine-triterpenes derivatives was evaluated on five tumor cell lines (Bel-7402, HepG2, HT-29, Hela, and MCF-7) using the standard MTT assay. In the study, the antineoplastic drug cisplatin (DDP) was selected as the positive control. The MDCK cell line was used to test the toxicity of the ligustrazine-triterpenes derivatives and DDP. IC50 values for different cell lines are reported in Table 1 . After combination with ligustrazine, most of the synthesized compounds showed significantly improved cytotoxicity compared to the starting materials. Among the candidates, compounds 1a, 1d, 4a and 4d exhibited much better antiproliferative activities than the starting materials on all tested cell lines. The cytotoxicity selectivity detection revealed that most of the ligustrazine-triterpenes derivatives exhibited low cytotoxicity towards MDCK cell. In particular, compound 4a exhibited better cytotoxic activity (IC50 < 5.23 μM) against Bel-7402, HT-29, MCF-7, Hela and HepG2 than the standard anticancer drug DDP, while it showed lower cytotoxicity (IC50 > 20 μM) than DDP (IC50 = 14.61 μM) on MDCK cells.
From the obtained results, it was observed that the derivatives containing single-ligustrazine substituents exhibited better antiproliferative activities than those containing bis-ligustrazine substituents, as exemplified by 1a > 1b, 2a > 2b, 3a > 3b, 4a > 4b. Structure-activity relationship analysis among 1a-1d, 2a-2d also revealed that the compounds with oleanane skeleton seemed to be more active than those with ursane skeleton, such as 1a > 2a, 1b > 2b, 1c > 2c, 1d > 2d, which was in agreement with the previously published study [23] . In addition, it was observed the derivatives containing single-ligustrazine substituents seemed to be more active than those with benzyl substituent at C-28 or C-30, such as 1d > 1c, 2d > 2c, 4d > 4c. These findings may provide a new framework for the design of new ligustrazine-triterpenes derivatives as anti-tumor drugs. Based on the above evidence, 4a (IC50 < 5.23 μM) was selected for further analysis including its cytotoxicity selectivity and its mechanism of growth inhibition on HepG2 cell lines. 
Computer Simulation of ClogP
Optimization of solubility and hydrophobicity is very important in the drug discovery process because these properties are closely associated with absorption, distribution, metabolism, and excretion (ADME) properties of the compounds [24] [25] [26] . LogP, the logarithm of the octanol/water partition coefficient, is the most widely used measure of the lipophilicity [27] . In this work, the logP values for these derivatives were calculated using the Sybyl-X 2.0 software (Tripos, Certara Inc., St. Louis, MO, USA). As shown in Table 1 , most of the derivatives with lower ClogP seemed to exhibited better anti-proliferative effects than those with higher ClogP, as exemplified by 1a, 1d > 1b, 1c; 2a, 2d > 2b, 2c; 4a, 4d > 4b, 4c. This was accordance with the previous study that triterpenes derivatives with lower Clogp display better cytotoxicity [12, 28] .
Preliminary Investigation of the Cytotoxicity Selectivity and the Apoptosis-Inducing Effect of 4a
Cytotoxicity Selectivity
The treatment with increased doses of 4a ( Figure 1 ) by MTT assay showed that the inhibition rate against MDCK was just about 26.50% at the concentration of 10 μM, while the inhibition rate against human hepatoma cell HepG2 was up to 99.87% at the same concentration. Therefore, at least in part, compound 4a had cytotoxicity selectively to human hepatocellular carcinoma cells in vitro. 
Morphological Observation of HepG2 Cells Using Giemsa Staining
Morphological analysis of HepG2 cells using Giemsa staining showed that the cells in control group appeared normal morphology whereas 4a treatment (2, 4, 8 μM for 72 h) caused evident nuclear fragmentation, chromatin condensation in a dose dependent manner (Figure 2 ), all of which were characteristic morphological alterations associated with apoptosis. To further characterize 4a-induced HepG2 cell apoptosis, the changes in cell morphology of the treated cells were determined using AO/EB double staining. AO is a vital dye that stains both live and dead cells as it can penetrate normal cell membrane. EB stains only cells that have lost their membrane integrity. Cells that stained green indicate viable cells, yellow indicate early apoptosis and orange/red indicate late apoptosis [29, 30] . As shown in Figure 4 , HepG2 cells in control group appeared bright green with normal cell morphology whereas the cells treated with 4a (2, 4, 8 μM) for 72 h showed an increased number of orange-and red-stained cells in a dose dependent manner. And characteristic changes of apoptosis, including condensation and fragmentation of nucleus and formation of apoptotic bodies, were observed in the cells treated with different concentrations of compound 4a. These results confirmed that 4a significantly induced apoptosis in HepG2 cells. 
Measurement of Mitochondrial Membrane Potential
Mitochondria play an essential role in the activation and progression of apoptosis. Mitochondrial membrane potential (ΔΨm) is an important parameter of mitochondrial function. Depolarization of ΔΨm is used as an early apoptotic maker in cells. In order to gain a better understand of the mechanism of 4a-induced HepG2 cells apoptosis, depolarization of ΔΨm was measured quantitatively by the fluorescent dye Rhodamine 123 (Rh123). As a cell-permeable cationic dye, Rh123 preferentially enters mitochondria based on the highly negative mitochondrial membrane potential. Depolarization of the membrane results in the loss of Rh123 from the mitochondria and a decrease in intracellular fluorescence intensity [31, 32] . Flow cytometric analysis of HepG2 cells after treatment with different concentrations of 4a (5 μM, 6 μM, 7 μM) for 72 h revealed that the fluorescent intensity decreased with the increase of 4a concentration ( Figure 6 ). That indicated 4a was able to induce mitochondrial membrane potential disruption in HepG2 cells. This was in agreement with other reports that betulinic acid and its derivatives could induce depolarization of mitochondrial transmembrane potential [33, 34] . concentrations is recognized as a factor for cell death or injury [35] . The level of intracellular free Ca 2+ is examined by the fluorescent dye Fluo-3AM. The Fluo-3 AM is converted to Fluo-3 upon deacetylation within the cells, and Fluo-3 increases green fluorescence upon Ca 2+ binding [36] . As shown in Figure 7 , with the increase of 4a concentration, the level of intracellular Ca 2+ increased steadily compared with the control group. As the concentration of 4a increased from 5.0 to 6.0 to 7.0 μM, intracellular free Ca 
Experimental Section
Chemistry
Reactions were monitored by TLC using silica gel coated aluminum sheets (Qingdao Haiyang Chemical Co., Qingdao, China) and visualized in UV light (254 nm). C-NMR assays were recorded on a BRUKER AVANCE 500 NMR spectrometer (Fällanden, Switzerland) with tetramethylsilane (TMS) as an internal standardm and chemical shifts are reported in δ (ppm). HR-MS were obtained by using Thermo Sientific TM LTQ Orbitrap XL hybrid FTMS instrument (Thermo Technologies, New York, NY, USA). Melting points (uncorrected) were measured at a rate of 5 °C/min using an X-5 micro melting point apparatus (Beijing, China). Cellular morphologies were observed using an inverted fluorescence microscope (Olympus IX71, Tokyo, Japan). Flash chromatography was performed using 200-300 mesh silica gel. The yields were calculated based on the last step reaction. All solvents and chemicals used were analytical or high-performance liquid chromatography grade.
2-(Bromomethyl)-3,5,6-trimethylpyrazine (1). Compound 1 was prepared according to our previously reported method [17] . The crude product, with 70% purity, was not purified further as it caused a strong mucous membrane irritation.
3,5,6-Trimethylpyrazine-2-carboxylic acid (2). Compound 2 was prepared according to the method described by Li et al., with minor modifications [37] . To a solution of trimethylpyrazine (5.0 g, 36.8 mmoL) in water (200 mL), aqueous potassium permanganate (KMnO4) solution (8.6 g KMnO4: 150 mL water) was added dropwise at room temperature over about 60 min. Upon completion of the addition, the mixture was stirred at 50 °C for 12 h, then the warm reaction mixture was filtered and washed with hot water (300 mL, 90 °C). The filtrate and washing liquor were combined, cooled to 0-5 °C, and the pH adjusted to 2.0 with concentrated hydrochloric acid. Extraction was performed with ethyl acetate (200 mL × 3), and the organic phase was dried with anhydrous sodium sulfate. The solvent was removed by distillation under vacuum, and the residue was recrystallized from acetone to produce a light yellow solid (2.39 g, yield: 47.8%), m.p.: 162-163 °C.
General Procedure for the Preparation of Ligustrazine-Triterpenes Derivatives 1a-4a
Compound 1 (5.0 mmoL) and the corresponding pentacyclic triterpenes (5.0 mmoL) were dissolved in 25 mL dry DMF, then K2CO3 (5.0 mmoL) was added and the mixture was kept at 85 °C for 1.5 h under nitrogen atmosphere. The warm reaction mixture was poured into ice-water and the crude product was extracted with ethyl acetate. After drying the organic layer over anhydrous Na2SO4 and evaporating the solvent under vacuum, the crude product was purified by flash chromatography (Petroleum ether:acetone = 10:1). 
General Procedure for the Preparation of Ligustrazine-Triterpenes Derivatives 1b-4b
To a solution of ligustrazine-triterpenes derivatives 1a-4a (1.0 mmoL) in dry dichloromethane (25 mL), compound 2 (1.2 mmoL), EDCI (1.5 mmoL), and DMAP (0.1 mmoL) were added. The mixture was allowed to stir at room temperature for 12 h under nitrogen atmosphere. Then the solution was washed with brine. After drying the organic layer over anhydrous Na2SO4 and evaporating the solvent under vacuum, the crude product was purified by flash chromatography (petroleum ether:acetone = 7:1). 
3β-Hydroxy-(3,5,6-trimethylpyrazin-2-carbonyl)-11-oxoolean-12-en-30-oic acid-3,5,6-trimethylpyrazin-2-methyl ester (3b)
. White powder, m.p.: 295.9-296.7 °C, yield 51.7%. The corresponding pentacyclic triterpenes (5.0 mmoL) and benzyl bromide (5.0 mmoL) were dissolved in 25 mL dry DMF, then K2CO3 (5.0 mmoL) was added and the mixture was kept at 85 °C for 2 h under nitrogen atmosphere. The warm reaction mixture was poured into ice-water and the crude product precipitated out. Then the crude product was filtered and the filtrate was washed with water, dried. The crude product was used without any further purification. (6) . White powder, m.p.: 92.9-93.7 °C, yield 94.1%. 
3β-Hydroxy-(3,5,6-trimethylpyrazin-2-carbonyl)-lup-20(29)-ene-28-oic acid-3,5,6-trimethylpyrazin-2-methyl ester (4b
3β-Hydroxyolea-12-en-28-oic acid-benzyl ester (4)
.
3β-Hydroxy-11-oxoolean-12-en-30-oic acid-benzyl ester
General Procedure for the Preparation of Ligustrazine-triterpenes Derivatives 1c-4c
The corresponding intermediates 4, 5, 6 and 7 (3.0 mmoL) was dissolved in 25 mL dry DCM, EDCI (3.5 mmoL), DMAP (0.3 mmoL) and compound 2 (3.5mmoL) were added. The mixture was stirred at room temperature for 12 h under nitrogen atmosphere. Then the solution was washed with brine, dried over sodium sulfate, filtered and the solvent was evaporated. Purification was performed by flash chromatography (petroleum ether:acetone = 8:1). 
3β-Hydroxyolea-(3,5,6-trimethylpyrazin-2-carbonyl)-12-en-28-oic acid-benzyl ester (1c
3β-Hydroxy-(3,5,6-trimethylpyrazin-2-carbonyl)-11-oxoolean-12-en-30-oic acid-benzyl ester (3c).
White powder, m.p.: 212.3-213.0 °C, yield 49.2%. 
General Procedure for the Preparation of Ligustrazine-Triterpenes Derivatives 1d-4d
Pd(OH)2/C (10%; 80 mg) was added to a solution of compound 1c-4c (1mmoL) in 30 mL MeOH. The mixture was stirred at room temperature for 12 h and filtered to remove Pd(OH)2/C. The filtrate was concentrated in vacuum and the residue was purified by flash chromatography (petroleum ether:acetone = 5:1). 15.4, 17.0, 17.2, 18.2, 22.9, 23.4, 23.6, 23.7, 25.9, 27.7, 28.2, 30.7, 32.5, 32.6, 33.1, 33.8, 37.0,  38.0, 38.2, 39.3, 41.0, 41.6, 45.9, 46.5, 47.6, 55.4, 83.0, 122.5, 143 
3β-Hydroxyolea-(3,5,6-trimethylpyrazin-2-carbonyl)-12-en-28-oic acid (1d
Bio-Evaluation Methods
Cell Culture
The cell lines Bel-7402 (human hepatocellular carcinoma), HepG2 (human hepatocellular carcinoma), HT-29 (human colon carcinoma), Hela (human cervical cancer), MCF-7 (human breast cancer) were included in this study. All these cell lines were provided by the Chinese Academy of Medical Sciences & Peking Union Medical College. Cultures were maintained as monolayers in RPMI 1640 supplemented with 10% (v/v) heat inactivated fetal bovine serum and 1% (v/v) enicillin/streptomycin (Thermo Technologies, New York, NY, USA) at 37 °C in a humidified atmosphere with 5% CO2. The ligustrazine derivatives under study were dissolved in DMSO (Sigma, St. Louis, MO, USA) and added at required concentrations to the cell culture. Cells incubated without the preparations served as the control.
Cytotoxicity Assay
The cytotoxicity of the compounds was evaluated on five cancer cell lines (Bel-7402, HepG2, HT-29, Hela, MCF-7) by the standard MTT assay. In short, exponentially growing cells were seeded into 96-well plates at a density 10 4 cells/mL. The plates were incubated at 37 °C in a humidified 5% CO2 atmosphere. Cells were allowed to adhere to the surface for 24 h and then treated with serial dilutions of the compounds for 72 h. Later, aliquots of [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) solution (20 μL, 5 mg/mL) were added to each well and the incubation was continued for an additional 4 h. Then the supernatant medium was thrown away. The dark blue formazan crystals formed within the healthy cells were solubilized with DMSO (150 μL) and the absorbance was measured in a plate reader (BIORAD 550 spectrophotometer, Bio-rad Life Science Development Ltd., Beijing, China) at 490 nm. Wells containing no drugs were used as control group. The IC50 values were defined as the concentration of compounds that produced a 50% reduction of surviving cells and calculated using Logit-method. Tumor cell growth inhibitory rate was calculated in the following Equation 
Mitochondrial Membrane Potential (ΔΨm) Analysis
The mitochondrial membrane potential was measured using rhodamine 123 (Rh123) staining and flow cytometry analysis. HepG2 cells (1 × 10 5 cells/mL) in logarithmic growth phase were seeded in 6-well culture plate and incuated for 24 h at 37 °C in incubator with 5% CO2. After treatment with different concentrations of 4a (5, 6, 7 μM) for 72 h, cells were collected and washed twice in cold PBS, then resuspended in 1 mL cell culture medium with Rh123 (10 μg/mL) (Rh123, Beijing BioDee Biotech. Co., Ltd., Beijing, China) and incubated for 30 min at 37 °C. After washed twice with cold PBS, the cells were immediately analyzed by the Flow Cytometer at 488 nm excitation wavelength [31, 35] cells/mL) in logarithmic growth phase were cultured in 6-well plates for 24 h at 37 °C in incubator with 5% CO2. After exposed to different concentrations of 4a (5, 6, 7 μM) for 72 h, cells were harvested and washed twice with cold PBS, then resuspended in HBSS buffer with 10 μM Fluo-3AM (Fluo-3AM, Shanghai Beyotime Biotech. Co., Ltd., Shanghai, China), and incubated for 30 min at 37 °C in the dark. Detection of intracellular Ca 2+ was carried out by the Flow Cytometer at 488 nm excitation wavelength [35, 36] .
Conclusions
In present study, several novel ligustrazine-triterpenes derivatives was designed and synthesized through combination bioactive pentacyclic triterpenes and ligustrazine. Their cytotoxicity was evaluated on five cancer cell lines (Bel-7402, HepG2, HT-29, Hela, and MCF-7) by the standard MTT assay, and their nephrotoxicity was tested using MDCK cells. The ClogP values of those derivatives were calculated by means of computer simulation. The antitumor activities screening indicated that, after coupling with ligustrazine, most of the synthesized compounds showed better antiproliferative activities than the starting materials. It also revealed that most of the derivatives with lower ClogP seemed to exhibit better anti-proliferative effects than those with higher ClogP, as exemplified by 1a, 1d > 1b, 1c;  2a, 2d > 2b, 2c; 4a, 4d > 4b, 4c . In particular, compound 4a exhibited better cytotoxic activity against Bel-7402, HT-29, MCF-7, Hela and HepG2 than DDP. Meanwhile, most of the candidates exhibited better selectivity towards MDCK cells. For example, at the concentration of 10 μM, the inhibition rate of 4a against MDCK was just about 26.50%, while the inhibition rate against human hepatoma cell HepG2 was up to 99.87% at the same concentration. Subsequent fluorescence staining and flow cytometry analysis indicated that 4a could induce apoptosis in HepG2 cell line. Further apoptosis mechanism investigation showed that 4a could also induce the depolarization of mitochondrial membrane potential and the disturbance of intracellular free Ca 2+ concentration. Further studies of the mechanisms of these compounds cytotoxic selectivity in human malignant tumors are currently underway. The results suggest that the attempt to apply structure combination to discover more efficient and lower toxicity anti-tumor lead compounds from nature products is viable.
